Overview

Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir

Status:
Terminated
Trial end date:
2019-05-10
Target enrollment:
Participant gender:
Summary
This study is being conducted to investigate the potential benefits of probiotic intake for preventing antibiotic associated diarrhea and Clostridium difficile infection in patients undergoing a systemic antibiotic treatment. The primary research question is: can daily intake of kefir, a yogurt-like food containing probiotics, reduce the incidence of diarrhea and Clostridium difficile infection in patients during antibiotic treatment?
Phase:
Phase 2
Details
Lead Sponsor:
St. Luke's Hospital of Duluth